Oral calcitonin (SMC021) does not a reduce the incidence of fractures.
SMC021 induced modest increases in vertebral, femur neck and hip BMD.
The exposure level was markedly lower than expected from earlier clinical studies.
This study highlights the need for better understanding oral delivery of peptides.